1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Life Science Data Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Life Science Data Management Market, by Data Type
8.1.1. Genomic and Sequence Data
8.1.1.1. Market Revenue and Forecast
8.1.2. Clinical Trial Data
8.1.2.1. Market Revenue and Forecast
8.1.3. Research and Experimental Data
8.1.3.1. Market Revenue and Forecast
8.1.4. Imaging Data
8.1.4.1. Market Revenue and Forecast
8.1.5. Manufacturing and Process Data
8.1.5.1. Market Revenue and Forecast
9.1. Life Science Data Management Market, by Solution / Offering
9.1.1. Data Storage and Archiving Solutions
9.1.1.1. Market Revenue and Forecast
9.1.2. Data Integration and Harmonization Tools
9.1.2.1. Market Revenue and Forecast
9.1.3. Software Platforms
9.1.3.1. Market Revenue and Forecast
9.1.4. Data Analytics and BI Tools
9.1.4.1. Market Revenue and Forecast
9.1.5. Workflow and Project Management Tools
9.1.5.1. Market Revenue and Forecast
10.1. Life Science Data Management Market, by Deployment Model
10.1.1. On-Premise Deployment
10.1.1.1. Market Revenue and Forecast
10.1.2. Cloud-Based / Hybrid Deployment
10.1.2.1. Market Revenue and Forecast
11.1. Life Science Data Management Market, by End User
11.1.1. Pharmaceutical Companies
11.1.1.1. Market Revenue and Forecast
11.1.2. Biotechnology Firms
11.1.2.1. Market Revenue and Forecast
11.1.3. Academic and Research Institutes
11.1.3.1. Market Revenue and Forecast
11.1.4. Contract Research Organizations (CROs)
11.1.4.1. Market Revenue and Forecast
11.1.5. Diagnostics and Clinical Laboratories
11.1.5.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Data Type
12.1.2. Market Revenue and Forecast, by Solution / Offering
12.1.3. Market Revenue and Forecast, by Deployment Model
12.1.4. Market Revenue and Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Data Type
12.1.5.2. Market Revenue and Forecast, by Solution / Offering
12.1.5.3. Market Revenue and Forecast, by Deployment Model
12.1.5.4. Market Revenue and Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Data Type
12.1.6.2. Market Revenue and Forecast, by Solution / Offering
12.1.6.3. Market Revenue and Forecast, by Deployment Model
12.1.6.4. Market Revenue and Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Data Type
12.2.2. Market Revenue and Forecast, by Solution / Offering
12.2.3. Market Revenue and Forecast, by Deployment Model
12.2.4. Market Revenue and Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Data Type
12.2.5.2. Market Revenue and Forecast, by Solution / Offering
12.2.5.3. Market Revenue and Forecast, by Deployment Model
12.2.5.4. Market Revenue and Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Data Type
12.2.6.2. Market Revenue and Forecast, by Solution / Offering
12.2.6.3. Market Revenue and Forecast, by Deployment Model
12.2.6.4. Market Revenue and Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Data Type
12.2.7.2. Market Revenue and Forecast, by Solution / Offering
12.2.7.3. Market Revenue and Forecast, by Deployment Model
12.2.7.4. Market Revenue and Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Data Type
12.2.8.2. Market Revenue and Forecast, by Solution / Offering
12.2.8.3. Market Revenue and Forecast, by Deployment Model
12.2.8.4. Market Revenue and Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Data Type
12.3.2. Market Revenue and Forecast, by Solution / Offering
12.3.3. Market Revenue and Forecast, by Deployment Model
12.3.4. Market Revenue and Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Data Type
12.3.5.2. Market Revenue and Forecast, by Solution / Offering
12.3.5.3. Market Revenue and Forecast, by Deployment Model
12.3.5.4. Market Revenue and Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Data Type
12.3.6.2. Market Revenue and Forecast, by Solution / Offering
12.3.6.3. Market Revenue and Forecast, by Deployment Model
12.3.6.4. Market Revenue and Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Data Type
12.3.7.2. Market Revenue and Forecast, by Solution / Offering
12.3.7.3. Market Revenue and Forecast, by Deployment Model
12.3.7.4. Market Revenue and Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Data Type
12.3.8.2. Market Revenue and Forecast, by Solution / Offering
12.3.8.3. Market Revenue and Forecast, by Deployment Model
12.3.8.4. Market Revenue and Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Data Type
12.4.2. Market Revenue and Forecast, by Solution / Offering
12.4.3. Market Revenue and Forecast, by Deployment Model
12.4.4. Market Revenue and Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Data Type
12.4.5.2. Market Revenue and Forecast, by Solution / Offering
12.4.5.3. Market Revenue and Forecast, by Deployment Model
12.4.5.4. Market Revenue and Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Data Type
12.4.6.2. Market Revenue and Forecast, by Solution / Offering
12.4.6.3. Market Revenue and Forecast, by Deployment Model
12.4.6.4. Market Revenue and Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Data Type
12.4.7.2. Market Revenue and Forecast, by Solution / Offering
12.4.7.3. Market Revenue and Forecast, by Deployment Model
12.4.7.4. Market Revenue and Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Data Type
12.4.8.2. Market Revenue and Forecast, by Solution / Offering
12.4.8.3. Market Revenue and Forecast, by Deployment Model
12.4.8.4. Market Revenue and Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Data Type
12.5.2. Market Revenue and Forecast, by Solution / Offering
12.5.3. Market Revenue and Forecast, by Deployment Model
12.5.4. Market Revenue and Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Data Type
12.5.5.2. Market Revenue and Forecast, by Solution / Offering
12.5.5.3. Market Revenue and Forecast, by Deployment Model
12.5.5.4. Market Revenue and Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Data Type
12.5.6.2. Market Revenue and Forecast, by Solution / Offering
12.5.6.3. Market Revenue and Forecast, by Deployment Model
12.5.6.4. Market Revenue and Forecast, by End User
13.1. IQVIA
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Veeva Systems
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Microsoft
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Oracle
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Optum
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Dassault Systèmes
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. SAP
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Abbott
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Abbott
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Abbott
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
